De Lorenzi, Federica
Rizzo, Larissa Yokota
Daware, Rasika
Motta, Alessandro
Baues, Maike
Bartneck, Matthias
Vogt, Michael
van Zandvoort, Marc
Kaps, Leonard
Hu, Qizhi
Thewissen, Marielle
Casettari, Luca
Rijcken, Cristianne J. F.
Kiessling, Fabian
Sofias, Alexandros Marios
Lammers, Twan
Funding for this research was provided by:
European Fund for Regional Development (0801767, 0801767)
European Research Council (Consolidator Grant 864121)
German Research Foundation (331065168, JPI Excellence Initiative, SFB1066, SFB1066, SFB1066)
German Federal Ministry of Research and Education (16GW0319K)
Deutsche Krebshilfe (SDK Postgraduate Program)
RWTH Aachen University
Article History
Accepted: 22 June 2022
First Online: 11 July 2022
Declarations
:
: Not applicable.
: All authors approve the publication.
: QH, MT, and CJFR are employees of Cristal Therapeutics. The other authors declare no competing interests.